A physician is considering starting abacavir on a patient diagnosed with HIV. Which of the following statements regarding abacavir is correct? (Select ALL that apply.)
A. This medication can cause a severe hypersensitivity reaction.
B. Patients must be screened for the HLA-B 1502 allele. If positive, the medication should not be given.
C. When combined with lamivudine, the brand name is Truvada.
D. Abacavir is a protease inhibitor.
E. The brand name is Ziagen.